Indication
Wet Age-Related Macular Degeneration
2 clinical trials
4 products
Clinical trial
A Phase 1/2 Dose-Escalation and Randomized, Controlled, Masked Expansion Trial of Intravitreal 4D-150 Gene Therapy in Adults With Neovascular (Wet) Age-Related Macular DegenerationStatus: Recruiting, Estimated PCD: 2024-11-01
Product
AfliberceptProduct
4D-150 IVTProduct
4D-150Clinical trial
A Randomized, Single-Masked, Active-Controlled Phase 2 Study of the Safety, Tolerability, and Efficacy of Repeated Doses of High-Dose Aflibercept in Patients With Neovascular Age-Related Macular DegenerationStatus: Completed, Estimated PCD: 2021-05-14
Product
aflibercept